The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Autoimmune Disease Diagnostics Market Research Report 2024
Synopsis
The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.
The global Autoimmune Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Diagnostics.
Report Scope
The Autoimmune Disease Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Disease Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disease Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
Euro Diagnostica
Autoimmune Technologies
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika
Phadia
Protagen
Segment by Type
Analyzers
Assay Kits
Segment by Application
Hospitals
Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Disease Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.
The global Autoimmune Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Diagnostics.
Report Scope
The Autoimmune Disease Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Disease Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disease Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
Euro Diagnostica
Autoimmune Technologies
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika
Phadia
Protagen
Segment by Type
Analyzers
Assay Kits
Segment by Application
Hospitals
Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Disease Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Analyzers
1.2.3 Assay Kits
1.3 Market by Application
1.3.1 Global Autoimmune Disease Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Research Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Diagnostics Market Perspective (2019-2030)
2.2 Autoimmune Disease Diagnostics Growth Trends by Region
2.2.1 Global Autoimmune Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autoimmune Disease Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Autoimmune Disease Diagnostics Market Dynamics
2.3.1 Autoimmune Disease Diagnostics Industry Trends
2.3.2 Autoimmune Disease Diagnostics Market Drivers
2.3.3 Autoimmune Disease Diagnostics Market Challenges
2.3.4 Autoimmune Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Diagnostics Players by Revenue
3.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue
3.4 Global Autoimmune Disease Diagnostics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Diagnostics Revenue in 2023
3.5 Autoimmune Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Diagnostics Breakdown Data by Type
4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2025-2030)
5 Autoimmune Disease Diagnostics Breakdown Data by Application
5.1 Global Autoimmune Disease Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autoimmune Disease Diagnostics Market Size (2019-2030)
6.2 North America Autoimmune Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Autoimmune Disease Diagnostics Market Size by Country (2019-2024)
6.4 North America Autoimmune Disease Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Disease Diagnostics Market Size (2019-2030)
7.2 Europe Autoimmune Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Autoimmune Disease Diagnostics Market Size by Country (2019-2024)
7.4 Europe Autoimmune Disease Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Autoimmune Disease Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Disease Diagnostics Market Size (2019-2030)
9.2 Latin America Autoimmune Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Autoimmune Disease Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Autoimmune Disease Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Autoimmune Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Autoimmune Disease Diagnostics Introduction
11.2.4 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Introduction
11.3.4 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 EUROIMMUN
11.4.1 EUROIMMUN Company Detail
11.4.2 EUROIMMUN Business Overview
11.4.3 EUROIMMUN Autoimmune Disease Diagnostics Introduction
11.4.4 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.4.5 EUROIMMUN Recent Development
11.5 Inova Diagnostics
11.5.1 Inova Diagnostics Company Detail
11.5.2 Inova Diagnostics Business Overview
11.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Introduction
11.5.4 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.5.5 Inova Diagnostics Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Detail
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Introduction
11.6.4 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.6.5 Roche Diagnostics Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Detail
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Introduction
11.7.4 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.7.5 Siemens Healthcare Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Autoimmune Disease Diagnostics Introduction
11.8.4 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.8.5 DiaSorin Recent Development
11.9 ERBA Diagnostics
11.9.1 ERBA Diagnostics Company Detail
11.9.2 ERBA Diagnostics Business Overview
11.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Introduction
11.9.4 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.9.5 ERBA Diagnostics Recent Development
11.10 Euro Diagnostica
11.10.1 Euro Diagnostica Company Detail
11.10.2 Euro Diagnostica Business Overview
11.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Introduction
11.10.4 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.10.5 Euro Diagnostica Recent Development
11.11 Autoimmune Technologies
11.11.1 Autoimmune Technologies Company Detail
11.11.2 Autoimmune Technologies Business Overview
11.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Introduction
11.11.4 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.11.5 Autoimmune Technologies Recent Development
11.12 Avant Diagnostics
11.12.1 Avant Diagnostics Company Detail
11.12.2 Avant Diagnostics Business Overview
11.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Introduction
11.12.4 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.12.5 Avant Diagnostics Recent Development
11.13 Exagen Diagnostics
11.13.1 Exagen Diagnostics Company Detail
11.13.2 Exagen Diagnostics Business Overview
11.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Introduction
11.13.4 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.13.5 Exagen Diagnostics Recent Development
11.14 Gold Standard Diagnostics
11.14.1 Gold Standard Diagnostics Company Detail
11.14.2 Gold Standard Diagnostics Business Overview
11.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Introduction
11.14.4 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.14.5 Gold Standard Diagnostics Recent Development
11.15 HOB Diagnostics
11.15.1 HOB Diagnostics Company Detail
11.15.2 HOB Diagnostics Business Overview
11.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Introduction
11.15.4 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.15.5 HOB Diagnostics Recent Development
11.16 HUMAN Diagnostics
11.16.1 HUMAN Diagnostics Company Detail
11.16.2 HUMAN Diagnostics Business Overview
11.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Introduction
11.16.4 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.16.5 HUMAN Diagnostics Recent Development
11.17 Immco Diagnostics
11.17.1 Immco Diagnostics Company Detail
11.17.2 Immco Diagnostics Business Overview
11.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Introduction
11.17.4 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.17.5 Immco Diagnostics Recent Development
11.18 ImmunArray
11.18.1 ImmunArray Company Detail
11.18.2 ImmunArray Business Overview
11.18.3 ImmunArray Autoimmune Disease Diagnostics Introduction
11.18.4 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.18.5 ImmunArray Recent Development
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Detail
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Autoimmune Disease Diagnostics Introduction
11.19.4 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.19.5 Myriad Genetics Recent Development
11.20 Omega Diagnostics
11.20.1 Omega Diagnostics Company Detail
11.20.2 Omega Diagnostics Business Overview
11.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Introduction
11.20.4 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.20.5 Omega Diagnostics Recent Development
11.21 ORGENTEC Diagnostika
11.21.1 ORGENTEC Diagnostika Company Detail
11.21.2 ORGENTEC Diagnostika Business Overview
11.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Introduction
11.21.4 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.21.5 ORGENTEC Diagnostika Recent Development
11.22 Phadia
11.22.1 Phadia Company Detail
11.22.2 Phadia Business Overview
11.22.3 Phadia Autoimmune Disease Diagnostics Introduction
11.22.4 Phadia Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.22.5 Phadia Recent Development
11.23 Protagen
11.23.1 Protagen Company Detail
11.23.2 Protagen Business Overview
11.23.3 Protagen Autoimmune Disease Diagnostics Introduction
11.23.4 Protagen Revenue in Autoimmune Disease Diagnostics Business (2019-2024)
11.23.5 Protagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
